http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0185034-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac9442e962452275a63c777abad46223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2342df74294a89a05ca55536344b739d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e414910c0755a5d84d6d84595d2d27c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0354d8cef23ac257594f21c83e1beeb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 1985-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e2f2bc2b35c053bd5c443b6350276c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50577cb2628b9a5ce04ad0a68bfa9d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a0fdba169fddc549dbb0689ae15d2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07812107b540a55c0338d75c4453b945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45b3399a1ee0b55d91d76a64f31ae2a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326ac8fa8a20e5f72e847a523a258221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef9052613ce882c74fc5d207adc4ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe4495d23eba12ed7b3fc0231a09203
publicationDate 1986-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0185034-A1
abstract A protein satisfying all the biological criteria characteristic of inhibin has been isolated from a gonadal source. The present invention describes the purification and characterization of inhibin and the use of the purified material to raise antibodies, the use of inhibin and said antisera in quantitative radioimmunoassay, as well as in vitro and in vivo inhibin and inhibin antibody. The present invention provides an inhibin, purified protein, characterized in that a) its apparent molecular weight determined by SDS-PAGE is 56,000 9E 1,000; b) its isoelectric point is between 6.9 and 7.3; c) this protein can specifically bind to concanavalin-A-sepharose; d) this protein is formed of two subunits, characterized in that i) their apparent molecular weights determined by SDS-PAGE are 44,000 9E 3,000 and 14,000 9E 2,000 respectively; ii) the isoelectric point of the 44,000 molecular weight subunit is between 6.0 and 7.0; iii) the N-terminal amino acid sequences of the two subunits are described in the present invention; e) this protein can suppress follicle stimulating hormone but not luteinizing hormone, thyroid stimulating hormone or prolactin in an in vitro biological analysis system; f) this protein can be labeled with radioactive iodine. Also provided is a method of isolating and purifying inhibin from the mammalian ovarian follicular fluid, characterized by a) one or more steps of gel penetration chromatography, b) one or more steps of reverse phase liquid chromatography of high yield, c) one or more steps of preparation polyacrylamide gel electrophoresis, d) electrophoretic elution of the purified inhibin.
priorityDate 1984-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8606076-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129773695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136069385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127686754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128769907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128993523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946

Total number of triples: 65.